1. Home
  2. BTGO vs IVA Comparison

BTGO vs IVA Comparison

Compare BTGO & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTGO

BitGo Holdings Inc. Class A Common Stock

N/A

Current Price

$7.48

Market Cap

1.2B

Sector

Finance

ML Signal

N/A

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$5.52

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTGO
IVA
Founded
2013
2011
Country
United States
France
Employees
N/A
84
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BTGO
IVA
Price
$7.48
$5.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
11
Target Price
$15.17
$15.91
AVG Volume (30 Days)
498.8K
236.1K
Earning Date
03-26-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$33.67
N/A
P/E Ratio
$10.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.60
$2.90
52 Week High
$15.30
$7.98

Technical Indicators

Market Signals
Indicator
BTGO
IVA
Relative Strength Index (RSI) 27.71 36.12
Support Level N/A $5.15
Resistance Level $10.24 $6.56
Average True Range (ATR) 0.65 0.29
MACD -0.26 -0.06
Stochastic Oscillator 5.24 4.29

Price Performance

Historical Comparison
BTGO
IVA

About BTGO BitGo Holdings Inc. Class A Common Stock

BitGo Holdings Inc provides various offerings to its clients including multi-signature blockchain wallet solutions allowing for secure storage, trade settlement, staking solutions, and lending of digital assets. The Company also provides professional services to develop smart contracts. Its clients range from crypto-native companies that use its self-custody wallet technology to traditional financial services firms that leverage its licensed custody, staking and trading capabilities within their own products and services.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: